Kidney cancer: PBRM1 loss promotes tumour response to immunotherapy

Kidney cancer: PBRM1 loss promotes tumour response to immunotherapyKidney cancer: PBRM1 loss promotes tumour response to immunotherapy, Published online: 23 January 2018; doi:10.1038/nrclinonc.2018.12Kidney cancer: PBRM1 loss promotes tumour response to immunotherapy

Source: Nature Clinical Practice Oncology - January 23, 2018 Category: Cancer & Oncology Authors: Grant Otto Source Type: research